Minimally-Invasive Realtime Assessment of Continuous Lactate in Exercise
NCT ID: NCT04238611
Last Updated: 2021-08-26
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
NA
15 participants
INTERVENTIONAL
2021-03-01
2022-03-01
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
The study will aim to validate a novel microneedle-based minimally invasive device for the continuous measurement of lactate during exercise.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Pilot Testing a Novel Non-invasive Lactate Sensor
NCT05649358
Estimating Blood [Lactate] Non-Invasively
NCT05036122
Proof-of-concept Study of LymphMonitor 1.0 to Assess the Lymphatic Vessel Function
NCT04393168
Sweat Sensors for Athletic Performance
NCT03566381
Evaluation of the Zynex Blood Volume Monitor in Healthy Adult Volunteers During a Blood Draw
NCT01834612
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
The measurement of the lactate trend requires multiple blood tests, and this can be uncomfortable. The need for repeated procedures may therefore restrict the full utility of the biomarker. Although point-of-care lactate measurements are possible, the barriers to initiating testing may also limit its role in clinical decision-making.
The aim of the study is the validation of the microneedle-based lactate biosensor for real-time continuous lactate measurement in healthy volunteers during exercise as proof-of-concept.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NA
SINGLE_GROUP
DEVICE_FEASIBILITY
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Lactate microneedle
Measurement of lactate through microneedle
Microneedle
Lactate microneedle applied on the skin of participant
Blood lactate measurement
Serum lactate testing through conventional laboratory methods
Exercise regimen
Standardised aerobic exercise regimen
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Microneedle
Lactate microneedle applied on the skin of participant
Blood lactate measurement
Serum lactate testing through conventional laboratory methods
Exercise regimen
Standardised aerobic exercise regimen
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
2. Healthy with no other previous medical history
3. Able to perform moderately intensive exercise without difficulty for at least 30 minutes continuously, and engages in regular aerobic exercise at least twice a week
Exclusion Criteria
2. Active soft tissue infection or infection at any site
3. Known hypersensitivity to any microneedle component or dressings
4. Presence of any implantable electronic devices such as a pacemaker or stimulators
18 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Imperial College London
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Alison H Holmes
Role: PRINCIPAL_INVESTIGATOR
Imperial College London
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Imperial College London
London, , United Kingdom
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Alison H Holmes, MD MPH MBBS
Role: primary
References
Explore related publications, articles, or registry entries linked to this study.
Ming DK, Jangam S, Gowers SA, Wilson R, Freeman DM, Boutelle MG, Cass AE, O'Hare D, Holmes AH. Real-time continuous measurement of lactate through a minimally invasive microneedle patch: a phase I clinical study. BMJ Innov. 2022 Apr;8(2):87-94. doi: 10.1136/bmjinnov-2021-000864. Epub 2022 Feb 28.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
19HH5646
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.